CN106913516A - A kind of blue syrup in Pu ground and its production and use - Google Patents
A kind of blue syrup in Pu ground and its production and use Download PDFInfo
- Publication number
- CN106913516A CN106913516A CN201710140800.7A CN201710140800A CN106913516A CN 106913516 A CN106913516 A CN 106913516A CN 201710140800 A CN201710140800 A CN 201710140800A CN 106913516 A CN106913516 A CN 106913516A
- Authority
- CN
- China
- Prior art keywords
- syrup
- ground
- blue
- extract
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006188 syrup Substances 0.000 title claims abstract description 62
- 235000020357 syrup Nutrition 0.000 title claims abstract description 62
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract description 48
- 239000000284 extract Substances 0.000 claims abstract description 44
- 239000003814 drug Substances 0.000 claims abstract description 41
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 31
- 239000010231 banlangen Substances 0.000 claims abstract description 30
- 238000002360 preparation method Methods 0.000 claims abstract description 30
- 206010061218 Inflammation Diseases 0.000 claims abstract description 16
- 241000245665 Taraxacum Species 0.000 claims abstract description 16
- 206010017553 Furuncle Diseases 0.000 claims abstract description 3
- 206010034038 Parotitis Diseases 0.000 claims abstract description 3
- 206010044008 tonsillitis Diseases 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 241000207929 Scutellaria Species 0.000 claims description 41
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 claims description 35
- 238000001914 filtration Methods 0.000 claims description 29
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 claims description 26
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 claims description 26
- 235000006193 cichoric acid Nutrition 0.000 claims description 26
- 229930016920 cichoric acid Natural products 0.000 claims description 26
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 claims description 26
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 26
- 108010010803 Gelatin Proteins 0.000 claims description 23
- 229920000159 gelatin Polymers 0.000 claims description 23
- 239000008273 gelatin Substances 0.000 claims description 23
- 235000019322 gelatine Nutrition 0.000 claims description 23
- 235000011852 gelatine desserts Nutrition 0.000 claims description 23
- 229930006000 Sucrose Natural products 0.000 claims description 22
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 22
- 229960004793 sucrose Drugs 0.000 claims description 22
- 239000004480 active ingredient Substances 0.000 claims description 19
- 239000012535 impurity Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000005720 sucrose Substances 0.000 claims description 18
- 235000003599 food sweetener Nutrition 0.000 claims description 17
- 239000003765 sweetening agent Substances 0.000 claims description 17
- 240000001949 Taraxacum officinale Species 0.000 claims description 15
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 13
- 235000004883 caffeic acid Nutrition 0.000 claims description 13
- 229940074360 caffeic acid Drugs 0.000 claims description 13
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- -1 corydlis bungeana Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 6
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 210000003800 pharynx Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 13
- 239000000470 constituent Substances 0.000 abstract description 9
- 201000007100 Pharyngitis Diseases 0.000 abstract description 3
- 230000002411 adverse Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 230000001953 sensory effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 238000002474 experimental method Methods 0.000 description 20
- 239000007788 liquid Substances 0.000 description 18
- 206010037660 Pyrexia Diseases 0.000 description 15
- 240000006688 Telosma cordata Species 0.000 description 14
- 235000017352 Telosma cordata Nutrition 0.000 description 14
- 239000012467 final product Substances 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 8
- 230000001741 anti-phlogistic effect Effects 0.000 description 8
- 235000008504 concentrate Nutrition 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 7
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 240000001307 Myosotis scorpioides Species 0.000 description 6
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000013558 reference substance Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 241001062009 Indigofera Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 208000038016 acute inflammation Diseases 0.000 description 5
- 230000006022 acute inflammation Effects 0.000 description 5
- 239000002260 anti-inflammatory agent Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 229920001864 tannin Polymers 0.000 description 5
- 235000018553 tannin Nutrition 0.000 description 5
- 239000001648 tannin Substances 0.000 description 5
- UZQVYLOFLQICCT-SCSAIBSYSA-N (R)-goitrin Chemical compound C=C[C@@H]1CNC(=S)O1 UZQVYLOFLQICCT-SCSAIBSYSA-N 0.000 description 4
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
- UZQVYLOFLQICCT-UHFFFAOYSA-N Goitrin Natural products C=CC1CNC(=S)O1 UZQVYLOFLQICCT-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 229960005305 adenosine Drugs 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 4
- 229960001544 sulfathiazole Drugs 0.000 description 4
- 206010014025 Ear swelling Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- UKIOTQZYKUPESG-JEOXALJRSA-N (1R,24S)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-2,4(8),9,15(23),16(20),21-hexaene Chemical compound C1=C2[C@H](C)[C@@H]3C4=CC(OCO5)=C5C=C4CCN3CC2=C2OCOC2=C1 UKIOTQZYKUPESG-JEOXALJRSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- PUHCFWFODBLSAP-UHFFFAOYSA-N Acetylisocorynoline Natural products C1=C2C3N(C)CC4=C(OCO5)C5=CC=C4C3(C)C(OC(C)=O)CC2=CC2=C1OCO2 PUHCFWFODBLSAP-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 2
- IQUGPRHKZNCHGC-UHFFFAOYSA-N Corynoline Natural products C1=C2C3N(C)CC4=C(OCO5)C5=CC=C4C3(C)C(O)CC2=CC2=C1OCO2 IQUGPRHKZNCHGC-UHFFFAOYSA-N 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- LINHZVMHXABQLB-ZDUSSCGKSA-N Isoboldine Chemical compound CN1CCC2=CC(OC)=C(O)C3=C2[C@@H]1CC1=C3C=C(OC)C(O)=C1 LINHZVMHXABQLB-ZDUSSCGKSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- BVGNIAWOQSCZOZ-UHFFFAOYSA-N N-methyl-zizyphine-B Natural products C1=CNC(=O)C2CCCN2C(=O)C2N(C(=O)C(NC(=O)C(C(C)CC)N(C)C)C(C)CC)CCC2OC2=CC=C(OC)C1=C2 BVGNIAWOQSCZOZ-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 239000004383 Steviol glycoside Substances 0.000 description 2
- VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 description 2
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 229930185929 Zizyphine Natural products 0.000 description 2
- GLRAHDCHUZLKKC-UHFFFAOYSA-N acetonitrile;2,2,2-trifluoroacetic acid;hydrate Chemical compound O.CC#N.OC(=O)C(F)(F)F GLRAHDCHUZLKKC-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 2
- 229940015301 baicalein Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- KZJWDPNRJALLNS-FBZNIEFRSA-N clionasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-FBZNIEFRSA-N 0.000 description 2
- WOLWLEQYUFDNTA-UHFFFAOYSA-N corycavine Chemical compound C1=C2C(=O)C(C)C3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 WOLWLEQYUFDNTA-UHFFFAOYSA-N 0.000 description 2
- IQUGPRHKZNCHGC-TYPHKJRUSA-N corynoline Chemical compound C1=C2[C@H]3N(C)CC4=C(OCO5)C5=CC=C4[C@@]3(C)[C@@H](O)CC2=CC2=C1OCO2 IQUGPRHKZNCHGC-TYPHKJRUSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- UKIOTQZYKUPESG-UHFFFAOYSA-N dl-Tetrahydrocoptisine Natural products C1=C2C(C)C3C4=CC(OCO5)=C5C=C4CCN3CC2=C2OCOC2=C1 UKIOTQZYKUPESG-UHFFFAOYSA-N 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 235000019411 steviol glycoside Nutrition 0.000 description 2
- 229930182488 steviol glycoside Natural products 0.000 description 2
- 150000008144 steviol glycosides Chemical class 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- MOFOLNOWFPVLGZ-BHWDSYMASA-N (2s,3s,4s,5r,6s)-6-(5,8-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC=CC=3)OC2=C1O MOFOLNOWFPVLGZ-BHWDSYMASA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- KNWVMRVOBAFFMH-HNNXBMFYSA-N (S)-scoulerine Chemical compound C1CN2CC(C(=C(OC)C=C3)O)=C3C[C@H]2C2=C1C=C(OC)C(O)=C2 KNWVMRVOBAFFMH-HNNXBMFYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- PLEOQAHCVRVCDL-UHFFFAOYSA-N 2,9-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1,10-diol Natural products CN1CCC2=CC(OC)=C(O)C3=C2C1CC1=C3C=C(O)C(OC)=C1 PLEOQAHCVRVCDL-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- PUHCFWFODBLSAP-WWNPGLIZSA-N Acetylcorynoline Chemical compound C1=C2[C@H]3N(C)CC4=C(OCO5)C5=CC=C4[C@@]3(C)[C@@H](OC(C)=O)CC2=CC2=C1OCO2 PUHCFWFODBLSAP-WWNPGLIZSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010007337 Azurin Proteins 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000437896 Corydalis bungeana Species 0.000 description 1
- GQEVCHQXWPWARL-UHFFFAOYSA-N Couroupitine A Natural products N1=CC=CC2=CC(=O)N3C4=CC=CC=C4C(=O)C3=C21 GQEVCHQXWPWARL-UHFFFAOYSA-N 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- ZUAPXIXLBSQDNW-UHFFFAOYSA-N Dihydroavicine Natural products Cc1cc2OCOc2c3CNc4c(ccc5cc6OCOc6cc45)c13 ZUAPXIXLBSQDNW-UHFFFAOYSA-N 0.000 description 1
- VXPARNCTMSWSHF-DNVSUFBTSA-N Dihydrosanguinarine Natural products O=C1[C@H](C(C)=C)C[C@]2(CO)[C@@H](C)[C@H](O)CCC2=C1 VXPARNCTMSWSHF-DNVSUFBTSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- URURFJJXWHZUAJ-UHFFFAOYSA-N Isocorynoline Natural products N1CC2=C3OCOC3=CC=C2C2(C)C1C1=CC(OCO3)=C3C=C1CC2O URURFJJXWHZUAJ-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000000103 Potentilla erecta Species 0.000 description 1
- 235000016551 Potentilla erecta Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- NWKHIZXZESQPSP-UHFFFAOYSA-N acetonitrile;phosphoric acid;hydrate Chemical group O.CC#N.OP(O)(O)=O NWKHIZXZESQPSP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- CIUHLXZTZWTVFL-UHFFFAOYSA-N dihydrosanguinarine Chemical compound C1=C2OCOC2=CC2=C3N(C)CC4=C(OCO5)C5=CC=C4C3=CC=C21 CIUHLXZTZWTVFL-UHFFFAOYSA-N 0.000 description 1
- HORZNQYQXBFWNZ-UHFFFAOYSA-N dl-Norisoboldin Natural products N1CCC2=CC(OC)=C(O)C3=C2C1CC1=C3C=C(OC)C(O)=C1 HORZNQYQXBFWNZ-UHFFFAOYSA-N 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N indirubin Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- CRSMCADHSFQBLA-UHFFFAOYSA-N isoboldine Natural products COc1cc-2c(CC3N(C)CCc4cccc-2c34)cc1O CRSMCADHSFQBLA-UHFFFAOYSA-N 0.000 description 1
- IQUGPRHKZNCHGC-JBACZVJFSA-N isocorynoline Chemical compound C1=C2[C@@H]3N(C)CC4=C(OCO5)C5=CC=C4[C@@]3(C)[C@@H](O)CC2=CC2=C1OCO2 IQUGPRHKZNCHGC-JBACZVJFSA-N 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- JWHHANVGNNWIRI-UHFFFAOYSA-N methanol phosphoric acid hydrate Chemical group O.OC.OP(O)(O)=O JWHHANVGNNWIRI-UHFFFAOYSA-N 0.000 description 1
- HKIWSNQLOOLXOH-UHFFFAOYSA-N methanol;2,2,2-trifluoroacetic acid;hydrate Chemical compound O.OC.OC(=O)C(F)(F)F HKIWSNQLOOLXOH-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- QKFAFSGJTMHRRY-FVDOMRANSA-M potassium;[(z)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N/OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-FVDOMRANSA-M 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- DJRZPPQHJDVOQW-UHFFFAOYSA-N scoulerine Natural products COc1cc2C3Cc4ccc(OC)c(O)c4CC3NCc2cc1O DJRZPPQHJDVOQW-UHFFFAOYSA-N 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- UXYJCYXWJGAKQY-UHFFFAOYSA-N stylopine Chemical compound C1C2=C3OCOC3=CC=C2CC2N1CCC1=C2C=C(OCO2)C2=C1 UXYJCYXWJGAKQY-UHFFFAOYSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses blue syrup in a kind of Pu ground and its production and use, belong to technical field of traditional Chinese medicine preparation.Syrup of the invention after dandelion, Radix Isatidis, the four kinds of extracted concentrations of Chinese herbal medicine of corydlis bungeana and the root of large-flowered skullcap by obtaining extract, it is prepared from according to special process, the syrup form for being adapted to take is made, adverse drug taste is effectively masked, medicine sensory issues are solved.Present invention improves extracting mode, greatly shorten extraction time, the content of principle active component is significantly improved, reduce medication dose, the effects such as with clearing heat and detoxicating, anti-inflammation detumescence, and active constituent content is high, taking dose is small, for treating the diseases such as parotitis, pharyngitis, tonsillitis or furuncle.The blue syrup in Pu ground of the present invention, is adapted to children taking.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation, more specifically to a kind of blue syrup in Pu ground and preparation method
And purposes.
Background technology
Pu ground indigo plant is made up of dandelion, Radix Isatidis, Chinese violet, the taste Chinese medicine of the root of large-flowered skullcap four, and effect is clearing heat and detoxicating, anti-inflammation detumescence.
Dandelion herb contains taraxasterol, choline, synanthrin, caffeic acid, pectin, taraxol, β-amyrin, beans steroid
Alcohol, cupreol, taraxerol, taraxacin, taraxacin and vitamin A, B, C etc..Wherein, dandelion it is effective into
Dividing includes caffeic acid and Cichoric acid.
Radix Isatidis contains indigo, indigo red, Anthraquinones, cupreol, clionasterol and several amino acids：Arginine, paddy
Propylhomoserin, tyrosine, proline, valine, GABA.Also contain potassium myronate, indigo, couroupitine A, 1- thiocyanic acid -2- hydroxyls
Base butyl- 3- alkene, table accuses Yichun, gland glucoside, palmitic acid, sucrose and the proteoglycan containing 12% amino acid.
Corydlis bungeana is the herb of bloodroot corydalis bungeana.Herb contains various alkaloids：Racemization and dextrorotation purple Dong
Alcohol spirit alkali, acetylcorynoline, Tetrahydrocoptisine, Biflorine, dextrorotation isocorynoline, tetrahydrocorysamine,
Dihydrosanguinarine, acetylisocorynoline, 11- epicorynolines, corycavine, BC, 12- hydroxyl corydalis alcohol
Clever alkali, scoulerine, broken leaf corydaline, big zizyphine removes the big zizyphine of first, isoboldine, dextrorotation Chinese violet corydaline, dextrorotation
13- epicorynolines.
The root of large-flowered skullcap mainly contains flavone compound：Scutelloside is the principle active component of the root of large-flowered skullcap, and molecular formula is C21H18O11, point
Son amount is 446.35, is yellow crystal, 223 DEG C of fusing point or faint yellow needle (methyl alcohol).
The existing blue sulfathiazole in Pu ground record in《People's Republic of China (PRC) drug standards Traditional Chinese medicine historical preparation the 3rd》, Pu Di
Blue oral liquid record in《Pharmacopoeia of People's Republic of China》2015 editions one.Particular advantages based on these four Chinese medicines, current city
It is on face to have the formulations such as Pu bring down a fever piece, sulfathiazole, antiphlogistic capsule more, it is safe using rear Small side effects.For example China is special
The patent application document of sharp Application No. 2006100837064 discloses a kind of anti-inflammation drugs and preparation method thereof, is related to Pu ground
Blue oral liquid and preparation method thereof；Chinese Patent Application No. is that 2005101080080 patent application document discloses Pu Dilan
The blue antiphlogistic granules in Pu ground prepared by the preparation method and the method for antiphlogistic granules；Chinese Patent Application No. is 2015104294371
Patent application document disclose the preparation method of the blue sulfathiazole in Pu ground.
Commercially available Pu ground indigo plant is clinically used, although determined curative effect, but curative effect plays slow, is primarily due to commercially available Pu ground
Active ingredient concentration in basket is low, and drug effect need further raising.Although in can improving Pu bring down a fever piece by concentration
Active constituent content, but can equally increase impurity content therein, bring certain side effect.
《Chinese Pharmacopoeia》2015 editions the 4th regulations：Syrup means the dense aqueous sucrose solution containing material medicine.Syrup
Agent is in production with storage：Amount containing sucrose should be not less than 45% (g/mL).
The content of the invention
1. the problem to be solved
There is a problem of that active ingredient is low, poor taste for the blue Chinese medicine in existing Pu ground, it is blue that the present invention provides a kind of Pu ground
Syrup and its production and use, effectively covers adverse drug smell, is made syrup form.Present invention improves extraction side
Formula, greatly shortens extraction time, and the content of principle active component is significantly improved, and reduces medication dose.By using rational work
Process extracts four traditional Chinese medicine thing, keeps and purify active constituents of medicine to greatest extent, is this so as to develop the stronger medicine of curative effect
One of inventive concept.The present invention compares commercially available Pu bring down a fever piece, with excellent in terms of active constituent content and curative effect of medication
Different effect.
2. technical scheme
In order to solve the above problems, the technical solution adopted in the present invention is as follows：
A kind of blue syrup in Pu ground, including corydlis bungeana, Radix Isatidis, dandelion and the root of large-flowered skullcap extract, also including sucrose, institute
The extract stated is by the weight portion of corydlis bungeana 1~3, the weight portion of Radix Isatidis 2~4, the weight portion of dandelion 6~9 and the weight of the root of large-flowered skullcap 2~4
Part is extracted to be concentrated to give；Then to sucrose is added in extract, cane sugar content is 45%~65% (g/mL) in making syrup,
Active ingredient includes scutelloside in extract, and the content of scutelloside is more than 10mg/mL in syrup；Impurity content is no more than 7%.
Further, active ingredient also includes Cichoric acid and caffeic acid, the content of Cichoric acid in syrup in extract
More than 1mg/mL, caffeinic content is more than 0.1mg/mL.
Further, described impurity is including protein, tannin, pigment, protocatechuic acid, Quercetin, cyanidenon etc..
Further, also including aromatic and preservative, the mass content of aromatic is 0.2%~1%, preservative
Mass content is 0.01%~0.5%, and wherein aromatic includes almond flavour, strawberry essence, orange flavor, lychee flavor, apple
Fruity essence, milk flavour, mango essence, lemon extract, chocolate essence, one or more in flavoring orange essence, preservative bag
Include one or more in sorbic acid, potassium sorbate, dehydroactic acid sodium, sodium lactate, ethyl, sodium citrate.
Further, also including sweetener, mass content is 0.2%~25%, and sweetener is that conventional edible adds
Plus agent, including high sweetener and low power sweetener, high sweetener be Aspartame, steviol glycoside, acesulfame potassium, honey element,
One or more in Sucralose；Low power sweetener is sorbierite, xylitol, honey, fructose, maltose, starch sugar, breast
Sugar, one or more in sucrose.
The one kind or several in salt, dextrin, maltodextrin, glycerine, CMC-Na can also be included in syrup preparation of the invention
Kind, content is 3%~10%.
A kind of preparation method of the above-mentioned blue syrup in Pu ground, comprises the following steps：
<1>The extract of corydlis bungeana, Radix Isatidis and dandelion is prepared, is comprised the following steps：
<a>Dandelion and Radix Isatidis are extracted twice with 15~20 times of water boiling and extractions, and each 1-2h adds gelatin 1-
5%, stand, filter to take supernatant；
<b>Corydlis bungeana is boiled twice with 15~20 times of decoctings, each 1-2h；
<c>By step<a>And step<b>Extract solution mixing, concentration adds shitosan to 0.1-2%, adjusts PH to 1-
2, stand, filtering；
<2>The extract of scutellaria is prepared, is comprised the following steps：
<d>Root of large-flowered skullcap ethanol is extracted and obtains alcohol extracting thing；
<e>Resulting alcohol extracting thing adds gelatin to 1-5%, and filtering, filtrate adds shitosan 0.1-2%, adjusts pH extremely
1-2, precipitate is Baical Skullcap root P.E, and described Baical Skullcap root P.E is scutelloside；
<3>The extract of corydlis bungeana, Radix Isatidis and dandelion is mixed with the extract of scutellaria, it is 0.8 to be concentrated into proportion
~1.3 (g/mL), cane sugar content is 45%~65% (g/mL) in adding sucrose to make preparation.
Further, the step<d>Middle 8~10 times 50%~70% of ethanol water is in 40-60 DEG C of condition
Lower ultrasonic wave extraction obtains alcohol extracting thing.
Step<a>And step<b>Operation order, step (1) and step (2) operation order to syrup system of the invention
The preparation of agent does not influence, and can first carry out step<b>Step is carried out again<a>；Step (2) can also first be carried out carries out step again
(1)。
The purposes of the above-mentioned blue syrup in a kind of Pu ground, with clearing heat and detoxicating or anti-inflammation detumescence medicine.
Further, for preparing treatment parotitis, pharyngitis, tonsillitis or the medicine of furuncle.
The above-mentioned blue syrup in Pu ground for prepare that child form is clearing heat and detoxicating or medicine of anti-inflammation detumescence in application.
3. beneficial effect
Compared to prior art, beneficial effects of the present invention are：
(1) the blue syrup in Pu ground of the invention is that herbal mixture is safe, effect is significant；In we, the root of large-flowered skullcap has clear
Effect of hot eliminating dampness, purging intense heat detoxicating；Dandelion has clearing heat and detoxicating, to clear liver and improve vision effect；Corydlis bungeana has clearing heat and detoxicating, work
Effect of blood detumescence；Radix Isatidis has functions that clearing heat and detoxicating, cool blood relieving sore-throat, the matching of four medicines, with good clearing heat and detoxicating, anti-
Effect of virus and antibacterial action；
(2) present invention overcomes the shortcomings of the blue Chinese medicine poor taste in Pu ground, by being added with the auxiliary material of flavored action, improves mouth
Taste, effectively covers adverse drug smell, is made syrup form, makes medication not be difficult matter；Overcome the existing blue tablet in Pu ground and capsule
The low defect of the water-insoluble formulation absorption difference such as agent, oral liquid formulation active constituent content, there is provided one kind be easy to absorb, effectively into
Divide formulation high；
(3) commercially available Pu ground indigo plant is clinically used, although determined curative effect, but curative effect plays slow, and drug effect need into one
Step is improved.The blue syrup antiphlogistic activity in Pu ground of the invention is improved, and extracting method of the invention is used in the enhancing of inflammation inhibiting rate, is made
Extraction time greatly reduces, and active ingredient is significantly improved, and its active ingredient includes scutelloside, Cichoric acid, caffeic acid, and the present invention is carried
The content of scutelloside in thing is taken more than 10mg/mL, the content of Cichoric acid is more than 1mg/mL, and caffeinic content is more than 0.1mg/
ML, this method root of large-flowered skullcap directly select ethanol water extraction, it is time-saving simultaneously, the recovery rate of active ingredient also increases
Plus, compared with commercially available Pu bring down a fever piece, antiphlogistic effects are good, the enhancing of inflammation inhibiting rate for the blue syrup in Pu ground of the invention；Compare
In the content for improving active principle by concentrating merely, in the absence of causing impurity content to increase, drug side-effect increases this method
Plus the shortcomings of；
(4) this method extracts scutelloside using ethanol water, and the content of the scutelloside for obtaining is high, then is precipitated by acid adding
Method, can effectively remove impurity component, obtain purity scutelloside higher；Extracted jointly using dandelion and Radix Isatidis
Method, the content of active ingredient Cichoric acid can be improved；
(5) active ingredient in the blue syrup in Pu ground of the present invention includes scutelloside, baicalein, wogonin, apiolin, witloof
Acid, caffeic acid, chlorogenic acid, forulic acid, corynoline, acetycorynoline, adenosine, epigoitrin etc., these are the master of said preparation
Want active component；In addition to active ingredient, remaining is the impurity of said preparation, including protein, tannin, pigment, protocatechuic acid, quercitrin
Element, cyanidenon etc.；Active constituent content is measured using high performance liquid chromatograph in present invention experiment, using coomassie
Light blue decoration method and ultraviolet specrophotometer etc. are no more than 7% to dirt content test, impurity content；
(6) the blue extracting method in existing Pu ground carries out alcohol precipitation this step after the extraction, although can improve the clarification of medicine
Spend, but active ingredient can be reduced, and the extracting method provided in the present invention does not exist such problem then, from certain density
Alcoholic solution, can not only increase recovery rate, moreover it is possible to suppress the dissolution of the macromolecule impurities such as tannin, be easy to Purification by filtration.Medicine is clear
Clear degree is high, and active constituent content is high so that the cost of extraction is substantially reduced；
(7) for preparation method, commercially available Pu bring down a fever piece is extracted using the method for water extraction, heavy acid, filtering, alkali soluble
, using half milling, the method for second half alcohol extracting extracts the root of large-flowered skullcap for scutelloside, the blue sulfathiazole in Pu ground, antiphlogistic capsule, antiphlogistic granules etc.
Glycosides, these method shortcomings are：If first, can not only increase extraction from certain density alcoholic solution during scutelloside extraction
Rate, moreover it is possible to suppress the dissolution of the macromolecule impurities such as tannin, be easy to Purification by filtration, so, compare water extraction method, selection alcohol extracting can increase
Plus recovery rate；Second, the root of large-flowered skullcap active compound material of milling is not completely soluble in water, it is only suitable for the solid dosage forms such as tablet, capsule, if
Raw material is crushed and is extracted, although the recovery rate of scutelloside can be increased, but also easily cause extractor filtering system simultaneously
The appearance of the problems such as blocking of system；
(8) present invention improves extracting mode, greatly shorten extraction time, the content of principle active component is significantly carried
Height, reduces medication dose；
(9) the blue syrup in Pu ground of the invention, compared to the blue preparation in more existing Pu ground, is especially suitable for children taking.
Brief description of the drawings
Fig. 1 is the standard curve schematic diagram of scutelloside of the present invention；
Fig. 2 is the standard curve schematic diagram of Cichoric acid of the present invention；
Fig. 3 is caffeinic standard curve schematic diagram of the invention；
Fig. 4 is the result of variations figure of mouse ear swelling degree in the present invention；
Fig. 5 is the chromatograms of the blue syrup in Pu ground of the present invention, and in figure, 1 represents adenosine；2 represent epigoitrin；3 represent coffee
Coffee acid；4 represent Cichoric acid；5 represent scutelloside；
Fig. 6 is the chromatograms of commercially available Pu bring down a fever piece, and in figure, 1 represents adenosine；2 represent epigoitrin；3 represent coffee
Coffee acid；4 represent Cichoric acid；5 represent scutelloside.
Specific embodiment
With reference to embodiment, the present invention is described further, as described below, is only to preferable implementation of the invention
Example, not does the limitation of other forms to the present invention, and any those skilled in the art are possibly also with the disclosure above
Technology contents be changed to the Equivalent embodiments of equal change.It is every without departing from the present invention program content, according to the present invention
Technical spirit any simple modification that following examples are done or equivalent variations, all fall within protection scope of the present invention.
Embodiment 1
The research of Extraction Process of Scuytellaria Baicalenksis
Tested by table 1-1,1-2,1-3 experiment table, compared with the peak height and peak area of the scutelloside of HPLC as index
More optimal extraction process.
One, experimental techniques
Tested by table 1-1,1-2,1-3,1-4 experiment table, every group is and weighs root of large-flowered skullcap 10g, plus alcohol reflux is extracted,
Merging extract solution, reclaims ethanol, and concentration, HPLC is detected, respectively to Extracting temperature, extraction concentration of alcohol used, extraction alcohol
The conditions such as amount, extraction time, pH, addition gelatin amount, addition shitosan amount carry out contrast optimization.
Two, experimentations
1. instrument and reagent：High performance liquid chromatograph (Agilent company)；Methyl alcohol is chromatographically pure, and water is up water, other examinations
It is pure that medicine is analysis.
2. chromatographic condition：It is filler with octadecylsilane chemically bonded silica；Mobile phase is methanol-water-phosphoric acid (44:56:
0.2)；Detection wavelength is 280nm, and flow velocity is 0.8mL/min.
3. the preparation of medicinal material solution：Precision measures this product 1mL, is placed in 50mL measuring bottles, plus methyl alcohol is to scale, shakes up.Essence
It is close to measure 5mL, it is placed in 10mL measuring bottles, plus methyl alcohol is to scale, shakes up, and obtains final product.
4. determination method：It is accurate respectively to draw reference substance solution and each 20 μ L of each group need testing solution, liquid chromatograph is injected,
It is measured under above-mentioned chromatographic condition, is obtained final product.
Three, experimental results
1. Extracting temperature and extraction concentration of alcohol experiment used
Table 1-1 Extracting temperatures and extraction concentration of alcohol experiment used
The experiment more than for peak area and peak height as can be seen that analyze：Extracting temperature P>0.05, there is no conspicuousness poor
It is different；Extracting mode P>0.05, there is no significant difference.Due to Extracting temperature and extract concentration of alcohol there are no significant difference, institute
So that with 50%~70% ethanol water, ultrasonic wave extraction obtains alcohol extracting thing under the conditions of 40-60 DEG C.
2. alcohol amount and extraction time experiment are extracted
Table 1-2 extracts alcohol amount and extraction time experiment
The experiment more than for peak area and peak height as can be seen that analyze：Extract alcohol amount P>0.05, there is no conspicuousness poor
It is different；Extraction time P<0.05, there is significant difference.Extraction alcohol amount used selects 8~10 times of ethanol, and extraction time is 2h.
3.pH, adds gelatin amount, adds the experiment of shitosan amount
Table 1-3 pH, add gelatin, add shitosan experiment
Contrasted by form：PH less, does not have significant difference in 1~2 pair of influence of peak area；Gelatin is added in 1-
It is little on peak area influence in the range of 5%, there is no significant difference；Add shitosan influences in 0.1-2% scopes on peak area
Less, there is no significant difference.So, alternative condition is：Gelatin to 1-5% is added, filtering, filtrate adds shitosan 0.1-
2%, adjust pH to 1-2, precipitate to be Baical Skullcap root P.E.
Four, roots of large-flowered skullcap techniques determine
2~4 parts of the root of large-flowered skullcap, with 8~10 times 50%~70% of ethanol water, ultrasonic wave extraction is obtained under the conditions of 40-60 DEG C
Alcohol extracting thing, 2 hours every time, merging filtrate, filtering, concentration added gelatin to 1-5%, and filtering, filtrate adds shitosan 0.1-
2%, adjust pH to 1-2, precipitate to be Baical Skullcap root P.E.
Dandelion, Chinese violet, the research of Extraction Technology of Radix Isatidis
Tested by table 2-1,2-2 experiment table, compared most with the peak height and peak area of the Cichoric acid of HPLC as index
Excellent extraction process.
One, experimental techniques
Tested by table 2-1,2-2 experiment table, every group is and weighs dandelion 12.5g, Radix Isatidis 4.7g, corydlis bungeana
3.125g, added water refluxing extraction, merges extract solution, and concentration, HPLC is detected.
Two, experimentations
1. instrument and reagent：High performance liquid chromatograph (Agilent company)；Acetonitrile is chromatographically pure, and water is up water, other examinations
It is pure that medicine is analysis.
2. chromatographic condition：It is filler with octadecylsilane chemically bonded silica；Mobile phase is acetonitrile-water-phosphoric acid (15:85:
0.2)；Detection wavelength is 326nm, and flow velocity is 0.8mL/min.
3. the preparation of medicinal material solution：Precision measures this product 1mL, and in putting 20mL measuring bottles, plus 70% ethanol shakes up to scale,
Obtain final product.
4. determination method：It is accurate respectively to draw reference substance solution and each 20 μ L of each group need testing solution, liquid chromatograph is injected,
It is measured under above-mentioned chromatographic condition, is obtained final product.
Three, experimental results
1. water and extraction time experiment are extracted
Table 2-1 extracts water and extraction time experiment
The experiment more than for peak area and peak height as can be seen that analyze：Extract water P>0.05, there was no significant difference；
Extraction time P>0.05, there was no significant difference.Difference that there are no significant due to extracting water and extraction time, so dandelion 6
~9 parts mix with 15~20 times of water boiling and extractions with 2~4 parts of Radix Isatidis, extract twice, each 1-2h, 1~3 part of use 15 of Chinese violet
~20 times of decoctings are boiled twice, each 1-2h, and both mix, filtering, concentration.
2. gelatin is added, shitosan is added, the pH for being adjusted is tested
Table 2-2 adds gelatin, adds shitosan, and the pH for being adjusted is tested
Contrasted by form：Add gelatin little on peak area influence in 0.1-2% scopes, there is no significant difference；pH
In 1~2 pair of influence of peak area less, there is no significant difference；Add shitosan influences not in 0.1-2% scopes on peak area
Greatly, there is no significant difference.So, alternative condition is：Dandelion and Radix Isatidis add gelatin 1-5% after extracting, and stand, filtering
Take supernatant；Concentrated after two kinds of extract solution mixing, add shitosan 0.1-2%, adjust pH to 1-2, stood, filtering.
Four, dandelions, Chinese violet, Extraction Technology of Radix Isatidis determine
2~4 parts with Radix Isatidis of 6~9 parts of dandelion mixes with 15~20 times of water boiling and extractions, extracts twice, each 1-2h,
Gelatin 1-5% is added, is stood, filter to take supernatant；1~3 part of Chinese violet, 15~20 times of use decocting is boiled twice, each 1-2h, and both mix
Close, filtering, concentration adds shitosan to 0.1-2%, adjusts PH to 1-2, stands, filtering.
HPLC determines active ingredient scutelloside, Cichoric acid, caffeinic content in Pu ground basket
One, experimentations
1. instrument and reagent：High performance liquid chromatograph (Agilent company)；Acetonitrile, methyl alcohol are chromatographically pure, and water is up water, its
It is pure that its reagent is analysis.
2. chromatographic condition：It is filler with octadecylsilane chemically bonded silica；
The testing conditions of scutelloside are：Mobile phase methanol-water-trifluoroacetic acid (44:56:0.2)；Detection wavelength is 280nm,
Flow velocity is 0.8mL/min, and column temperature is 30 DEG C, the μ L of sample size 20.
The testing conditions of Cichoric acid are：Mobile phase acetonitrile-water-trifluoroacetic acid (22:78:0.2)；Detection wavelength is 326nm,
Flow velocity is 0.8mL/min, and column temperature is 30 DEG C, the μ L of sample size 20.
Caffeinic testing conditions are：Mobile phase acetonitrile-water-trifluoroacetic acid (9:91:0.2)；Detection wavelength is 323nm,
Flow velocity is 0.8mL/min, and column temperature is 30 DEG C, the μ L of sample size 20.
3. the preparation of reference substance solution：
Precision weighs scutelloside standard items in right amount, plus methyl alcohol is made the reference substance storing solution that mass concentration is 0.32mg/mL,
Gradient dilution.Scutelloside standard liquid concentration to be matched somebody with somebody：0mg/mL、0.01mg/mL、0.02mg/mL、0.04mg/mL、0.08mg/
mL、0.16mg/mL、0.32mg/mL。
Precision weighs Cichoric acid standard items in right amount, plus methyl alcohol is made the reference substance storing solution that mass concentration is 0.32mg/mL,
Gradient dilution.Cichoric acid standard liquid concentration to be matched somebody with somebody：0mg/mL、0.0025mg/mL、0.005mg/mL、0.01mg/mL、
0.02mg/mL、0.04mg/mL、0.08mg/mL、0.16mg/mL、0.32mg/mL。
Precision weighs caffeic acid standard items in right amount, plus methyl alcohol is made the reference substance storing solution that mass concentration is 0.1mg/mL,
Gradient dilution.Caffeic acid standard liquid concentration to be matched somebody with somebody：0mg/mL、0.0015625mg/mL、0.003125mg/mL、
0.00625mg/mL、0.0125mg/mL、0.025mg/mL、0.05mg/mL、0.1mg/mL。
4. the preparation of medicinal material solution：Compare this method extraction Pu ground it is blue with commercially available Pu bring down a fever piece and they effectively into
The assay for dividing.
Determine the preparation of scutelloside medicinal material solution：Precision measures 1mL, is placed in 50mL measuring bottles, plus methyl alcohol is to scale, shakes
It is even.Precision measures 5mL, is placed in 10mL measuring bottles, plus methyl alcohol is to scale, shakes up, and obtains final product.
Determine the preparation of Cichoric acid medicinal material solution：Precision measures 1mL, and in putting 20mL measuring bottles, plus 70% ethanol shakes to scale
It is even, obtain final product.
Determine the preparation of caffeic acid medicinal material solution：Precision measures 1mL, and in putting 20mL measuring bottles, plus 70% ethanol shakes to scale
It is even, obtain final product.
5. determination method：It is accurate respectively to draw each standard solution and each 20 μ L of each group need testing solution, inject liquid chromatogram
Instrument, is measured under above-mentioned chromatographic condition, obtains final product.With sample introduction concentration as abscissa, peak area is ordinate, draws standard bent
Line, obtains regression equation.
Two, results
1. content of baicalin is calculated
If Fig. 1 is scutelloside standard curve：Y=63447x+96.002 (R2=0.9994), substitute into standard curve and obtain, this
The blue amount containing scutelloside in Pu ground that method is extracted is 0.15mg/mL, i.e., the Pu ground for being extracted per 1mL this method is blue and after being made syrup
13.8mg/mL containing scutelloside, the content of scutelloside is more than 10mg/mL in syrup.Record in《Pharmacopoeia of People's Republic of China》
The Pu bring down a fever piece requirement of 2015 editions one：Per 1mL 6.0mg is not less than containing scutelloside.Compare therewith, active ingredient scutelloside
Content greatly increase.
2. Cichoric acid cubage
If Fig. 2 is Cichoric acid standard curve：Y=106854x-520.11 (R2=0.9927), substitute into standard curve and obtain city
The content of Cichoric acid in Pu bring down a fever piece is sold for 0.01mg/mL, blue amount of the syrup containing Cichoric acid in the Pu ground that this method is extracted is
0.08mg/mL, i.e., per the commercially available Pu bring down a fever piece 0.32mg/mL containing Cichoric acid of 1mL, the blue sugar in Pu ground extracted per 1mL this method
Slurry 1.64mg/mL containing Cichoric acid.
3. caffeic acid cubage
If Fig. 3 is caffeic acid standard curve：Y=111154x+57.693 (R2=0.9998), substitute into standard curve and obtain city
Caffeinic content is 0.002mg/mL in selling Pu bring down a fever piece, and the blue syrup in Pu ground that this method is extracted is containing caffeinic amount
0.011mg/mL, i.e., per the commercially available Pu bring down a fever piece 0.038mg/mL containing caffeic acid of 1mL, per the Pu Dilan that 1mL this method is extracted
Syrup 0.212mg/mL containing caffeic acid.
Embodiment 2
Anti- small white mouse acute inflammation pharmacological experiment study
One, test materials
Animal：24 icr mouse, male, body weight is in 25g or so
Medicine：Made syrup
Two, test methods
Healthy mice 24, random point 3 groups, every group 8：Blank, the commercially available Pu bring down a fever piece of purchase, this laboratory
The made blue syrup in Pu ground.
6h and 1h is administered once respectively before causing acute inflammation model, and each blank control group and administration group small white mouse are distinguished
Gavage 0.21mL/10g body weight physiological saline and corresponding liquid.
Laboratory mouse first determines the wide thickness of mouse right ear respectively at 1h after administration, then in the wide instillation of auris dextra
0.07mL dimethylbenzene, mouse ear swelling degree is determined every 15min with slide measure, to instill the thickness of ear after dimethylbenzene
The difference of the thickness of ear before instilling is subtracted as inflammatory swelling degree index, and on the basis of blank control group inflammation swelling,
Calculate each administration group inflammation inhibiting rate.
Three, result of the tests
Fig. 4 is the change that mouse ear swelling degree is determined with slide measure；Table 5-1 is caused for syrup paraxylene of the present invention
The inflammation inhibiting rate of the inflammatory swelling degree index of small white mouse ear acute inflammation and each administration group 15min and 30min.By Fig. 4 and
Table 5-1 understands that small white mouse ear acute inflammation caused by paraxylene, syrup of the present invention has obvious antiphlogistic effects, with blank pair
Compared according to group, there is significant difference, and compared with commercially available Pu bring down a fever piece, the enhancing of inflammation inhibiting rate.
Table 5-1 syrup paraxylene of the present invention causes the inflammatory swelling degree index and each administration group of small white mouse ear acute inflammation
Inflammation inhibiting rate
Note：Compared with blank control group, t inspections, * p<0.05, * * p<0.01, n=8
Embodiment 3
The blue syrup in Pu ground
Dandelion 100g, Chinese violet 25g, Radix Isatidis 37.6g, root of large-flowered skullcap 37.6g, sucrose 130g.
<1>Dandelion 100g, Radix Isatidis 37.6g mixing plus 15 times of decoctings are boiled twice, add gelatin 1%, 1h are stirred, to it
It is completely dissolved, stands, takes supernatant.
<2>Chinese violet 25g adds 15 times of decoctings to boil twice, is cooled to room temperature, filtering.
Step<1>And step<2>Order on extract without influence.
<3>Extract solution<1>With<2>Both mixing, filtering, it is 1.1 to be concentrated into density, adds shitosan to 0.1%, regulation
PH to 2, stands, and filtering removes precipitation.
<4>Root of large-flowered skullcap 37.6g 8 times of 50% ethanol of amount, in 40 DEG C of ultrasonic wave extraction alcohol extractings twice, each 2h, extract solution mistake
Miscellaneous, addition gelatin 1% in filtrate is filtered, 1h is stirred, is completely dissolved to it, stood, filter to take supernatant, filtrate adds shitosan
2%, hydrochloric acid adjusts pH to 2, stands 12h, and precipitate is Baical Skullcap root P.E.
<5>Baical Skullcap root P.E is added<3>In gained concentrate, it is well mixed, is settled to 200mL, obtains traditional Chinese medicine extraction
Thing concentrate.
<6>The sucrose of 130g will be added in the concentrated liquid of tradition Chinese medicine, heating is dissolved it, stirred and evenly mixed, sterilize 30min, obtains final product.
Embodiment 4
The blue syrup in Pu ground
Dandelion 75g, Chinese violet 12.5g, Radix Isatidis 25g, root of large-flowered skullcap 25g, sucrose 110g.
<1>Dandelion 75g, Radix Isatidis 25g mixing plus 20 times of decoctings are boiled twice, add gelatin 5%, stir 1h, complete to its
CL, stands, and takes supernatant.
<2>Chinese violet 12.5g adds 20 times of decoctings to boil twice, is cooled to room temperature, filtering.
<3>Extract solution<1>With<2>Both mixing, filtering, it is 0.9 to be concentrated into density, adds shitosan to 0.1%, regulation
PH to 2, stands, and filtering removes precipitation.
<4>Root of large-flowered skullcap 25g 10 times of 60% ethanol of amount, in 60 DEG C of ultrasonic wave extraction alcohol extractings twice, each 2h, extract solution filtering
Removal of impurities, adds gelatin 5%, stirs 1h, is completely dissolved to it, stands, and filters to take supernatant, and filtrate adds shitosan 0.1%, hydrochloric acid
PH to 1 is adjusted, 12h is stood, precipitate is Baical Skullcap root P.E.
<5>Baical Skullcap root P.E is added<3>In gained concentrate, it is well mixed, is settled to 250mL, obtains traditional Chinese medicine extraction
Thing concentrate.
<6>The sucrose of 110g will be added in the concentrated liquid of tradition Chinese medicine, heating is dissolved it, stirred and evenly mixed, sterilize 30min, obtains final product.
Embodiment 5
The blue syrup in Pu ground
Dandelion 112.5g, Chinese violet 37.5g, Radix Isatidis 50g, root of large-flowered skullcap 50g, sucrose 90g.
<1>Dandelion 112.5g, Radix Isatidis 50g mixing plus 15 times of decoctings are boiled twice, add gelatin 3%, 1h are stirred, to it
It is completely dissolved, stands, takes supernatant.
<2>Chinese violet 37.5g adds 15 times of decoctings to boil twice, is cooled to room temperature, filtering.
<3>Extract solution<1>With<2>Both mixing, filtering, it is 1.1 to be concentrated into density, adds shitosan to 1%, adjusts PH
To 1, stand, filtering removes precipitation.
<4>Root of large-flowered skullcap 50g 8 times of 50% ethanol of amount, in 60 DEG C of ultrasonic wave extraction alcohol extractings twice, each 2h, extract solution filtering
Removal of impurities, adds gelatin 5%, stirs 1h, is completely dissolved to it, stands, and filters to take supernatant, and filtrate adds shitosan 0.1%, hydrochloric acid
PH to 1 is adjusted, 12h is stood, precipitate is Baical Skullcap root P.E.
<5>Carried scutelloside is added<3>In gained concentrate, it is well mixed, is settled to 200mL, obtains traditional Chinese medicine extraction
Thing concentrate.
<6>The sucrose of 90g will be added in the concentrated liquid of tradition Chinese medicine, heating is dissolved it, stirred and evenly mixed, sterilize 30min, obtains final product.
Embodiment 6
The blue syrup in Pu ground
Dandelion 75g, Chinese violet 12.5g, Radix Isatidis 25g, root of large-flowered skullcap 25g, sucrose 120g, flavoring apple essence 1g, sorbierite 1g, lemon
Lemon acid sodium 0.4g.
<1>Dandelion 75g, Radix Isatidis 25g mixing plus 20 times of decoctings are boiled twice, add gelatin 3%, stir 1h, complete to its
CL, stands, and takes supernatant.
<2>Chinese violet 12.5g adds 20 times of decoctings to boil twice, is cooled to room temperature, filtering.
<3>Extract solution<1>With<2>Both mixing, filtering, it is 1.0 to be concentrated into density.
<4>Root of large-flowered skullcap 25g 10 times of 70% ethanol of amount, in 40 DEG C of ultrasonic wave extraction alcohol extractings twice, each 2h, extract solution filtering
Removal of impurities, adds gelatin 5%, stirs 1h, is completely dissolved to it, stands, and filters to take supernatant, and filtrate adds shitosan 2%, hydrochloric acid to adjust
PH to 1, stands 12h, and precipitate is Baical Skullcap root P.E.
<5>Baical Skullcap root P.E is added<1>In gained concentrate, it is well mixed, is settled to 200mL, obtains traditional Chinese medicine extraction
Thing concentrate.
<6>The sucrose of 120g will be added in the concentrated liquid of tradition Chinese medicine, heating dissolves it, adds flavoring apple essence 1g, sorbierite 1g,
Sodium citrate 0.4g, stirs and evenly mixs, and sterilize 30min, obtains final product.
Flavoring apple essence in the present embodiment can be replaced with the conventional aromatic such as almond flavour, strawberry essence, orange flavor,
Mass content scope of the aromatic in syrup is between 0.2%~1%.Sucrose and sorbierite can with conventional
Edible high sweetener or low power sweetener are replaced, and high sweetener can be Aspartame, steviol glycoside etc., low power sweetener
Can be maltose, xylitol, honey etc., when the sweetener in syrup is high sweetener, sweetener is in syrup
Mass content it is low, for example, it may be 0.2%；When the sweetener in syrup is low power sweetener, sweetener is in syrup
In mass content it is high, for example, it may be 25%.Sodium citrate can be using conventional sorbic acid, sorbic acid as preservative
Potassium, dehydroactic acid sodium etc. are replaced, and mass content scope is between 0.01%~0.5%.
Embodiment 7
The blue impurity research in Pu ground
Active ingredient in the blue syrup in Pu ground of the present invention has scutelloside, baicalein, wogonin, apiolin, Cichoric acid, coffee
Coffee acid, chlorogenic acid, forulic acid, corynoline, acetycorynoline, adenosine, epigoitrin etc., be the chief active of said preparation into
Point.In addition to active ingredient, remaining is the impurity of said preparation, including protein, tannin, pigment, protocatechuic acid, Quercetin, sweet-scented osmanthus
Careless element etc..
The present invention experiment in active constituent content is measured using high performance liquid chromatograph, by each peak peak height with
Peak area can be seen that active ingredient and impurity content how much.Step is with embodiment 2.
Fig. 5 is the chromatograms of the blue syrup in Pu ground of the present invention.Wherein active ingredient, for example：Peak 4 is Cichoric acid, peak area
It is 5953.59, peak height is 123.85, this peak accounts for the 9.50% of total peak area；Peak 5 is scutelloside, and peak area is 39159.10, peak
A height of 613.21, this peak accounts for the 62.45% of total peak area.
Fig. 6 is the chromatograms of commercially available Pu bring down a fever piece.Wherein active ingredient, for example：Peak 4 is Cichoric acid, peak area
It is 1527.84, peak height is 31.93, this peak accounts for the 4.28% of total peak area；Peak 5 is scutelloside, and peak area is 2.6358.00, peak
A height of 406.33, this peak accounts for the 53.97% of total peak area.
Two figures of contrast are as can be seen that active constituent content of the present invention is high.
Also, the result of dirt content test is obtained by dying method with coomassie brilliant blue and ultraviolet specrophotometer etc., this
Invention protein impurities content is 220ug/mL or so, and commercially available Pu ground azurin impurity content is 300ug/mL or so.
The result of dirt content test is drawn with reference to chromatograms and ultraviolet specrophotometer etc., what the present invention was determined
Impurity content is no more than 7%.
The present invention is described according to preferred embodiment.It should be understood that description above and embodiment are only
In order to demonstrate the invention.On the premise of without departing from the spirit and scope of the present invention, those skilled in the art can be with
Various alternatives of the invention and improvement project are designed, it all should be understood to be within protection scope of the present invention.
Claims (11)
1. the blue syrup in a kind of Pu ground, it is characterised in that：Extract including corydlis bungeana, Radix Isatidis, dandelion and the root of large-flowered skullcap, also wraps
Sucrose is included, described extract is by the weight portion of corydlis bungeana 1~3, the weight portion of Radix Isatidis 2~4, the weight portion of dandelion 6~9 and the root of large-flowered skullcap
2~4 weight portions are extracted to be concentrated to give；Cane sugar content is 45%~65% (g/mL) wherein in syrup, in extract effectively
Composition includes scutelloside, and the content of scutelloside is more than 10mg/mL in syrup；Impurity content is no more than 7%.
2. the blue syrup in Pu according to claim 1 ground, it is characterised in that：Active ingredient also includes Cichoric acid in extract
And caffeic acid, the content of Cichoric acid is more than 1mg/mL in syrup, and caffeinic content is more than 0.1mg/mL.
3. the blue syrup in Pu according to claim 1 and 2 ground, it is characterised in that：Also include aromatic and preservative, fragrance
The mass content of agent is 0.2%~1%, and the mass content of preservative is 0.01%~0.5%.
4. the blue syrup in Pu according to claim 1 and 2 ground, it is characterised in that：Also include sweetener, mass content is
0.2%~25%.
5. the preparation method of the blue syrup in a kind of Pu ground described in claim 1, it is characterised in that：Comprise the following steps：
<1>The extract of corydlis bungeana, Radix Isatidis and dandelion is prepared, is comprised the following steps：
<a>Dandelion and Radix Isatidis water boiling and extraction, add gelatin 1-5% in extract solution, stand, and filter to take supernatant；
<b>Corydlis bungeana water boiling and extraction；
<c>By step<a>And step<b>Extract solution mixing, concentration adds shitosan to 0.1-2%, and pH is to 1-2 for regulation, quiet
Put, filter；
<2>The extract of scutellaria is prepared, is comprised the following steps：
<d>Root of large-flowered skullcap ethanol is extracted and obtains alcohol extracting thing；
<e>Resulting alcohol extracting thing adds gelatin to 1-5%, and filtering adds shitosan 0.1-2%, adjusts pH to 1- in filtrate
2, precipitate is Baical Skullcap root P.E, and described Baical Skullcap root P.E is scutelloside；
<3>The extract of corydlis bungeana, Radix Isatidis and dandelion is mixed with the extract of scutellaria, it is 0.8~1.3 to be concentrated into proportion
(g/mL) cane sugar content is 45%~65% (g/mL) during, addition sucrose makes preparation.
6. the preparation method of the blue syrup in Pu according to claim 5 ground, it is characterised in that：The step<d>It is middle with 8~
10 times 50%~70% of ethanol water ultrasonic wave extraction under the conditions of 40-60 DEG C obtains alcohol extracting thing.
7. the preparation method of the blue syrup in Pu according to claim 5 ground, it is characterised in that：In step (a) and step (b)
Each extraction time is 1~2h.
8. the preparation method of the blue syrup in Pu ground according to claim 5 or 7, it is characterised in that：In step (a) with 15~
20 times of water are decocted to dandelion and Radix Isatidis and extracted twice；Corydlis bungeana is decocted with 15~20 times of water in step (b) and is extracted twice.
9. the purposes of the blue syrup in Pu ground described in claim 1, it is characterised in that：There is clearing heat and detoxicating or anti-inflammatory for preparing
The medicine of detumescence.
10. the purposes of the blue syrup in Pu according to claim 9 ground, it is characterised in that：For preparing treatment parotitis, pharynx
The medicine of scorching, tonsillitis or furuncle.
The blue syrup in Pu ground described in 11. claim 1-4 is for preparing, child form is clearing heat and detoxicating or medicine of anti-inflammation detumescence
Application in thing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710140800.7A CN106913516B (en) | 2017-03-10 | 2017-03-10 | A kind of Pudilan syrup and its production and use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710140800.7A CN106913516B (en) | 2017-03-10 | 2017-03-10 | A kind of Pudilan syrup and its production and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106913516A true CN106913516A (en) | 2017-07-04 |
| CN106913516B CN106913516B (en) | 2018-03-30 |
Family
ID=59461750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710140800.7A Ceased CN106913516B (en) | 2017-03-10 | 2017-03-10 | A kind of Pudilan syrup and its production and use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106913516B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010407A (en) * | 2018-09-11 | 2018-12-18 | 华润三九（雅安）药业有限公司 | A kind of Radix Isatidis syrup and preparation method thereof |
| CN116898921A (en) * | 2023-08-10 | 2023-10-20 | 江西新世纪民星动物保健品有限公司 | Preparation method of cattail and dyer woad compound traditional Chinese medicine preparation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101204424A (en) * | 2006-12-22 | 2008-06-25 | 天津中新药业集团股份有限公司 | Composite of traditional Chinese traditional medicine for clearing away heat and toxic, antiinflammatory, detumescence and preparation method thereof |
| CN103989751A (en) * | 2014-05-08 | 2014-08-20 | 天津科技大学 | Flocculating purification process for Pudilan Chinese medicinal water extract |
| CN104940301A (en) * | 2015-05-31 | 2015-09-30 | 黑龙江佰彤儿童药物研究有限公司 | Pudilan children's antiviral oral pellet gel and preparation method thereof |
-
2017
- 2017-03-10 CN CN201710140800.7A patent/CN106913516B/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101204424A (en) * | 2006-12-22 | 2008-06-25 | 天津中新药业集团股份有限公司 | Composite of traditional Chinese traditional medicine for clearing away heat and toxic, antiinflammatory, detumescence and preparation method thereof |
| CN103989751A (en) * | 2014-05-08 | 2014-08-20 | 天津科技大学 | Flocculating purification process for Pudilan Chinese medicinal water extract |
| CN104940301A (en) * | 2015-05-31 | 2015-09-30 | 黑龙江佰彤儿童药物研究有限公司 | Pudilan children's antiviral oral pellet gel and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 国家药典委员会: "《中华人民共和国药典：2015年版.一部》", 30 June 2015, 中国医药科技出版社 * |
| 张超云等: "《药剂学》", 31 October 2013, 辽宁大学出版社有限公司 * |
| 曹光明: "《中药浸提物生产工艺学》", 31 January 2009, 化学工业出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010407A (en) * | 2018-09-11 | 2018-12-18 | 华润三九（雅安）药业有限公司 | A kind of Radix Isatidis syrup and preparation method thereof |
| CN116898921A (en) * | 2023-08-10 | 2023-10-20 | 江西新世纪民星动物保健品有限公司 | Preparation method of cattail and dyer woad compound traditional Chinese medicine preparation |
| CN116898921B (en) * | 2023-08-10 | 2024-05-31 | 江西新世纪民星动物保健品有限公司 | Preparation method of cattail and dyer woad compound traditional Chinese medicine preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106913516B (en) | 2018-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062077B (en) | Method for preparing stevia whole stevioside and stevia whole flavone at the same time | |
| CN101336987B (en) | Preparation method of total flavone of Hovenia dulcisThunb | |
| CN101002841B (en) | Effective components of rose, its preparing method and use | |
| CN1931270B (en) | Sobering up and liver protecting Chinese medicine preparation and its preparation process | |
| KR102123972B1 (en) | Pharmaceutical composition for treating headache, and preparation method thereof | |
| KR20120123064A (en) | Pharmaceutical composition including sunflower extract, preparative method and use thereof | |
| CN112972547A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency syndrome and preparation method and application thereof | |
| CN107050142A (en) | It is a kind of to improve the Chinese medicine composition of sleep | |
| CN106913717A (en) | The preparation method and purposes of a kind of Pu bring down a fever piece | |
| CN105963390A (en) | Preparation method of Shuganning preparation | |
| CN106913516B (en) | A kind of Pudilan syrup and its production and use | |
| CN101816723B (en) | Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof | |
| CN101757099A (en) | Desmodium-capillary artemisia cholecystagogue, preparation method and quality control method thereof | |
| CN102274260B (en) | Medicinal composition of notoginseng root extract and preparation method thereof | |
| Li | Chinese herbal medicine | |
| CN109620906A (en) | It is a kind of for preventing and treating the composition of alcoholic liver injury and antialcoholism action | |
| CN104435045A (en) | Traditional Chinese medicine composition for treating stroke and sequela thereof and preparation method thereof | |
| CN104224952A (en) | Preparation method for total anthraquinones of rheum officinale with stable and uniform proportions of all components | |
| CN101439152A (en) | Chinese medicinal composition for treating pearl eye as well as preparation method thereof and quality control method | |
| CN106928376A (en) | The separation method of skunk bush polysaccharide and its application | |
| CN100391491C (en) | Medicine composition for treating cardiovascular diseases and preparation method thereof | |
| CN102429994A (en) | Compound heartleaf houttuynia herb mixture and preparation method thereof | |
| KR20170073938A (en) | A composition for treating dry eye syndrome comprising a extract of Vaccinium Uliginosum as an active ingredient | |
| CN105343163A (en) | Preparation method for lamiophlomis rotata extract and application thereof | |
| CN103977163B (en) | Medicinal composition with myocardial ischemia resisting effect, preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20171220 Address after: Xianlin Xianlin University City streets HintCAD road in Qixia District of Nanjing City, Jiangsu province 210000 F7 No. 9 Building 1 room 104 Applicant after: Jiangsu medical Wade Biological Technology Co., Ltd. Address before: 210000 the 6 floor of the red maple Science Park, A7, Qixia District, Nanjing, Jiangsu Applicant before: Nanjing Anji Biotechnology Co., Ltd. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181206 Address after: 211100 No. 105, 34 Building, Wenboyuan, Longmian Avenue, Jiangning District, Nanjing City, Jiangsu Province Patentee after: Xu Hanmei Address before: 210000 Room 104, 1/F, Building F7, 9 Weidi Road, Xianlin University Town, Xianlin Street, Qixia District, Nanjing, Jiangsu Province Patentee before: Jiangsu medical Wade Biological Technology Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190627 Address after: 211100 No. 105, 34 Building, Wenboyuan, Longmian Avenue, Jiangning District, Nanjing City, Jiangsu Province Co-patentee after: Qi Weiyan Patentee after: Xu Hanmei Address before: 211100 No. 105, 34 Building, Wenboyuan, Longmian Avenue, Jiangning District, Nanjing City, Jiangsu Province Patentee before: Xu Hanmei |
|
| TR01 | Transfer of patent right | ||
| IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20190730 Decision number of declaring invalidation: 41099 Granted publication date: 20180330 |
|
| IW01 | Full invalidation of patent right |